STAT2 and acute myeloid leukemia: BMSCs are also IL6 secreting cells, and studies have shown that IL6 derived from AML-BMSCs can promote chemotherapy resistance and epithelial-mesenchymal transition (EMT) in AML through the IL6-STAT2/3 signaling pathway [18].